Published in J Clin Epidemiol on June 01, 1997
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ (2003) 8.55
Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ (2005) 6.66
Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ (2003) 6.61
Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation. BMJ (2001) 5.77
Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews. BMJ (2009) 3.18
Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis. Osteoporos Int (2012) 2.81
Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. Lancet (2009) 2.81
Graphical tools for network meta-analysis in STATA. PLoS One (2013) 2.66
Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers. Nat Rev Drug Discov (2010) 2.63
Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study. BMJ (2013) 2.52
Review and meta-analysis of couple-oriented interventions for chronic illness. Ann Behav Med (2010) 2.47
Trials and fast changing technologies: the case for tracker studies. BMJ (2000) 2.46
Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis. CMAJ (2011) 2.40
Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials. Med Decis Making (2013) 2.39
The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med (2007) 2.16
Rank reversal in indirect comparisons. Value Health (2012) 2.13
Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health (2006) 1.91
Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study. BMJ (2011) 1.86
Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis. Osteoporos Int (2006) 1.79
Evaluation of inconsistency in networks of interventions. Int J Epidemiol (2013) 1.72
Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. Clin Interv Aging (2008) 1.72
Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer (2009) 1.69
Indirect comparisons: a review of reporting and methodological quality. PLoS One (2010) 1.65
Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. Osteoporos Int (2011) 1.55
Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers. BMC Med (2013) 1.54
Network meta-analysis using R: a review of currently available automated packages. PLoS One (2014) 1.48
Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants. BMC Med (2012) 1.46
Which is the best laparoscopic approach for inguinal hernia repair: TEP or TAPP? A systematic review of the literature with a network meta-analysis. Surg Endosc (2012) 1.45
Developments in post-marketing comparative effectiveness research. Clin Pharmacol Ther (2007) 1.42
Characteristics and knowledge synthesis approach for 456 network meta-analyses: a scoping review. BMC Med (2017) 1.39
An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy. PLoS One (2016) 1.39
Metastatic renal cell cancer treatments: an indirect comparison meta-analysis. BMC Cancer (2009) 1.37
Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis. BMC Med (2009) 1.37
Using Meta-analysis to Compare the Efficacy of Medications for Attention-Deficit/Hyperactivity Disorder in Youths. P T (2009) 1.36
Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis. BMJ (2012) 1.33
A graphical tool for locating inconsistency in network meta-analyses. BMC Med Res Methodol (2013) 1.31
Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects. Bull World Health Organ (2009) 1.29
Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis. Ann Rheum Dis (2003) 1.28
Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes (2012) 1.26
Once-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterol. Int J Chron Obstruct Pulmon Dis (2014) 1.25
Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review. BMJ (2013) 1.22
Comparing effects of kyphoplasty, vertebroplasty, and non-surgical management in a systematic review of randomized and non-randomized controlled studies. Eur Spine J (2012) 1.17
Multiple treatment comparison meta-analyses: a step forward into complexity. Clin Epidemiol (2011) 1.16
The rough guide to systematic reviews and meta-analyses. HSR Proc Intensive Care Cardiovasc Anesth (2011) 1.16
Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis. Am J Obstet Gynecol (2012) 1.15
Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev (2010) 1.15
Incorporating multiple interventions in meta-analysis: an evaluation of the mixed treatment comparison with the adjusted indirect comparison. Trials (2009) 1.15
Comparative efficacy of pharmacologic interventions in preventing relapse of Crohn's disease after surgery: a systematic review and network meta-analysis. Gastroenterology (2014) 1.14
Multiple treatment comparisons in epilepsy monotherapy trials. Trials (2007) 1.14
The quality of reporting methods and results in network meta-analyses: an overview of reviews and suggestions for improvement. PLoS One (2014) 1.13
Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev (2010) 1.13
The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. CMAJ (2008) 1.12
Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews. Cochrane Database Syst Rev (2012) 1.11
Estimating the power of indirect comparisons: a simulation study. PLoS One (2011) 1.11
Palliative surgery versus medical management for bowel obstruction in ovarian cancer. Cochrane Database Syst Rev (2010) 1.10
Low-intensity pulsed ultrasonography versus electrical stimulation for fracture healing: a systematic review and network meta-analysis. Can J Surg (2014) 1.10
A comment on Boyers et al.: "eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a NICE single technology appraisal". Pharmacoeconomics (2013) 1.09
Bioequivalence between generic tacrolimus products marketed in Spain by adjusted indirect comparison. Eur J Clin Pharmacol (2012) 1.09
Characteristics of networks of interventions: a description of a database of 186 published networks. PLoS One (2014) 1.08
Simulation evaluation of statistical properties of methods for indirect and mixed treatment comparisons. BMC Med Res Methodol (2012) 1.06
Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis. Harm Reduct J (2009) 1.06
No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosis. Adv Ther (2014) 1.05
Comparative effectiveness of induction therapy for human immunodeficiency virus-associated cryptococcal meningitis: a network meta-analysis. Open Forum Infect Dis (2015) 1.03
48-week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-infected patients: a systematic review and network meta-analysis. PLoS One (2014) 1.01
Angiogenesis inhibitors for the treatment of ovarian cancer. Cochrane Database Syst Rev (2011) 1.01
Measures used to treat contrast-induced nephropathy: overview of reviews. Br J Radiol (2013) 1.00
The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women. BMC Musculoskelet Disord (2011) 0.99
Meta-analysis of the combination of TNF inhibitors plus MTX compared to MTX monotherapy, and the adjusted indirect comparison of TNF inhibitors in patients suffering from active rheumatoid arthritis. Rheumatol Int (2007) 0.98
Mirtazapine versus other antidepressive agents for depression. Cochrane Database Syst Rev (2011) 0.98
Hormonal therapy in advanced or recurrent endometrial cancer. Cochrane Database Syst Rev (2010) 0.97
Standardization of misleading immunoassay based 25-hydroxyvitamin D levels with liquid chromatography tandem-mass spectrometry in a large cohort study. PLoS One (2012) 0.96
Interventions for central serous chorioretinopathy: a network meta-analysis. Cochrane Database Syst Rev (2015) 0.96
Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysis. Ther Clin Risk Manag (2012) 0.95
Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: systematic review and network meta-analysis reveals the need for long term comparator trials. Br J Clin Pharmacol (2013) 0.94
Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review. BMJ Open (2013) 0.94
A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer. BMC Med (2014) 0.94
ENERgized vessel sealing systems versus CONventional hemostasis techniques in thyroid surgery--the ENERCON systematic review and network meta-analysis. Langenbecks Arch Surg (2013) 0.93
Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study. Br J Sports Med (2015) 0.93
Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database Syst Rev (2010) 0.93
Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis. Clin Res Cardiol (2014) 0.92
Indirect bioequivalence assessment using network meta-analyses. Eur J Clin Pharmacol (2014) 0.92
Indirect comparison meta-analysis of aspirin therapy after coronary surgery. BMJ (2003) 0.92
Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma. Cochrane Database Syst Rev (2011) 0.91
Tamoxifen for relapse of ovarian cancer. Cochrane Database Syst Rev (2010) 0.91
Sample size and power considerations in network meta-analysis. Syst Rev (2012) 0.91
Chemoradiation for advanced primary vulval cancer. Cochrane Database Syst Rev (2011) 0.91
Effects of treatment with fluoride on bone mineral density and fracture risk--a meta-analysis. Osteoporos Int (2007) 0.90
Effect of combination therapy on joint destruction in rheumatoid arthritis: a network meta-analysis of randomized controlled trials. PLoS One (2014) 0.89
Systematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME). BMC Ophthalmol (2015) 0.89
Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison. Br J Clin Pharmacol (2014) 0.89
Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer. Cochrane Database Syst Rev (2010) 0.88
Network meta-analysis for comparing treatment effects of multiple interventions: an introduction. Rheumatol Int (2014) 0.88
Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison. BMC Cancer (2008) 0.88
Interpreting estimates of treatment effects: implications for managed care. P T (2008) 0.88
Fluvoxamine versus other anti-depressive agents for depression. Cochrane Database Syst Rev (2010) 0.88
Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials (1989) 15.99
Guidelines for reading literature reviews. CMAJ (1988) 10.90
Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. JAMA (1994) 10.80
Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol (1994) 9.50
Development and validation of a questionnaire to measure asthma control. Eur Respir J (1999) 9.35
The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J (1985) 8.06
How to keep up with the medical literature: V. Access by personal computer to the medical literature. Ann Intern Med (1986) 7.36
Users' guides to the medical literature. I. How to get started. The Evidence-Based Medicine Working Group. JAMA (1993) 6.83
Measuring quality of life in children with asthma. Qual Life Res (1996) 6.76
A consumer's guide to subgroup analyses. Ann Intern Med (1992) 6.34
Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. JAMA (2000) 5.94
Measuring disease-specific quality of life in clinical trials. CMAJ (1986) 5.56
Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax (1992) 5.37
Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med (1994) 5.19
Measuring quality of life in asthma. Am Rev Respir Dis (1993) 4.97
A test for seasonality of events with a variable population at risk. Br J Prev Soc Med (1975) 4.95
Randomised controlled trial of respiratory rehabilitation. Lancet (1994) 4.74
Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics (1984) 4.73
Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet (1996) 4.65
Assessing the minimal important difference in symptoms: a comparison of two techniques. J Clin Epidemiol (1996) 4.55
Validation of an index of the quality of review articles. J Clin Epidemiol (1991) 4.54
Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. JAMA (1988) 4.46
Effect of encouragement on walking test performance. Thorax (1984) 4.44
Practitioners of evidence based care. Not all clinicians need to appraise evidence from scratch but all need some skills. BMJ (2000) 4.41
Need for expertise based randomised controlled trials. BMJ (2005) 4.34
A comparison of methods to detect publication bias in meta-analysis. Stat Med (2001) 4.22
The science of reviewing research. Ann N Y Acad Sci (1993) 4.15
Estimation of the duration of a pre-clinical disease state using screening data. Am J Epidemiol (1983) 4.11
Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med (1998) 4.01
Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J (1999) 4.00
Interpreting treatment effects in randomised trials. BMJ (1998) 3.97
Empirical evidence of bias in infertility research: overestimation of treatment effect in crossover trials using pregnancy as the outcome measure. Fertil Steril (1996) 3.91
The estimation and interpretation of attributable risk in health research. Biometrics (1976) 3.90
Systematic implementation of an advance directive program in nursing homes: a randomized controlled trial. JAMA (2000) 3.87
Measuring quality of life in the parents of children with asthma. Qual Life Res (1996) 3.82
The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. Am J Hypertens (1999) 3.72
Canadian physicians' attitudes about and preferences regarding clinical practice guidelines. CMAJ (1997) 3.56
Users' guides to the medical literature. JAMA (1993) 3.56
Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA (2001) 3.32
Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med (1997) 3.28
Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA (1996) 3.21
Intention-to-treat principle. CMAJ (2001) 3.20
A reappraisal of the kappa coefficient. J Clin Epidemiol (1988) 3.13
Estimating the error rates of diagnostic tests. Biometrics (1980) 3.08
Determinants in Canadian health care workers of the decision to withdraw life support from the critically ill. Canadian Critical Care Trials Group. JAMA (1995) 3.08
Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials. Ann Intern Med (1998) 3.07
Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology (1992) 3.06
Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS (1999) 3.04
Clinical impact versus factor analysis for quality of life questionnaire construction. J Clin Epidemiol (1997) 2.98
Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. JAMA (1996) 2.98
How to keep up with the medical literature: I. Why try to keep up and how to get started. Ann Intern Med (1986) 2.94
When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment. J Clin Epidemiol (2001) 2.84
Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest (1992) 2.81
Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy (1991) 2.80
Payments for care at private for-profit and private not-for-profit hospitals: a systematic review and meta-analysis. CMAJ (2004) 2.76
A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas (1996) 2.74
Residents' experiences of abuse, discrimination and sexual harassment during residency training. McMaster University Residency Training Programs. CMAJ (1996) 2.71
Reamed versus nonreamed intramedullary nailing of lower extremity long bone fractures: a systematic overview and meta-analysis. J Orthop Trauma (2000) 2.69
The rational clinical examination. Is this patient having a myocardial infarction? JAMA (1998) 2.66
Validation of a model of gross motor function for children with cerebral palsy. Phys Ther (2000) 2.65
How should we measure function in patients with chronic heart and lung disease? J Chronic Dis (1985) 2.61
User's guide to the orthopaedic literature: how to use an article about a surgical therapy. J Bone Joint Surg Am (2001) 2.58
Clinical recommendations using levels of evidence for antithrombotic agents. Chest (1995) 2.52
Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2002) 2.50
An index of scientific quality for health reports in the lay press. J Clin Epidemiol (1993) 2.47
Calculation of attributable risks from epidemiological data. Int J Epidemiol (1978) 2.39
Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life. Med Care (2001) 2.36
Sensitivity to change of the Roland-Morris Back Pain Questionnaire: part 1. Phys Ther (1998) 2.35
Treatment of open fractures of the shaft of the tibia. J Bone Joint Surg Br (2001) 2.33
Selective decontamination of the digestive tract. An overview. Chest (1994) 2.28
Should unpublished data be included in meta-analyses? Current convictions and controversies. JAMA (1993) 2.26
A framework for clinical evaluation of diagnostic technologies. CMAJ (1986) 2.26
Children and adult perceptions of childhood asthma. Pediatrics (1997) 2.25
Agreement among reviewers of review articles. J Clin Epidemiol (1991) 2.25
Practice guidelines. What are internists looking for? J Gen Intern Med (1996) 2.17
Should study subjects see their previous responses? J Chronic Dis (1985) 2.17
Coding ordinal independent variables in multiple regression analyses. Am J Epidemiol (1987) 2.15
Transferring evidence from research into practice: 1. The role of clinical care research evidence in clinical decisions. ACP J Club (1996) 2.10
Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trials. JAMA (1996) 2.08
Prevention for multifactorial diseases. Am J Epidemiol (1980) 2.05
How to use an article on therapy or prevention: pneumonia prevention using subglottic secretion drainage. Crit Care Med (1997) 2.03
Improved scaling of the gross motor function measure for children with cerebral palsy: evidence of reliability and validity. Phys Ther (2000) 1.96